Cimiside E

Cat. No.: IBDI-431268

Cimiside E (25-Anhydrocimigenol xyloside) is a triterpene xyloside, Cimiside E possesses apoptotic action on gastric cancer cells, with an IC50 value of 14.58 μM. Cimiside E induces cell cycle arrest at G2/M phase, and mediates apoptosis through the induction of the caspase cascade for both the extrinsic and intrinsic pathways.

Product Details

Target	Caspase
Molecular Weight	602.80
Synonyms	25-Anhydrocimigenol xyloside
SMILES	C[[email protected]]12[[email protected]@]3([H])[[email protected]@]4(CC[[email protected]@]1([[email protected]]5([H])[[email protected]@]6(O[[email protected]]([[email protected]@H](O6)C(C)=C)([H])C[[email protected]]5C)[[email protected]@H]2O)C)[[email protected]@]7([[email protected]@](C(C)([[email protected]](CC7)O[[email protected]]8[[email protected]@H]([[email protected]]([[email protected]@H](CO8)O)O)O)C)([H])CC3)C4
Structure Classification	Terpenoids>Triterpenes

Storage & Handling

Shipping	Room temperature in continental US. May vary elsewhere.
Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.